Drugs / Lipofundin MCT/LCT
last change Feb 2008 re-read 2 minutes ago

Lipofundin MCT/LCT

Developed for
parenteral nutrition-associated cholestasis · pulmonary immaturity

Trials 0

Also used as a comparator or background therapy in 1 trial
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT00497289 Comparator Jan 2006 → Feb 2008 parenteral nutrition-associated cholestasis, pulmonary immaturity B. Braun Melsungen AG Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Lipofundin MCT/LCT ClinicalTrials.gov intervention name — accepted as the source's own label NCT00497289
Route Intravenous “daily i.v. infusion for up to 5 days” NCT00497289